Study of the Association Between Sacroiliitis/Axial Spondylarthritis and Giant Cell Arteritis/ Polymyalgia Rheumatica
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHôpital NOVO
About this trial
The purpose of the study is to recruit as many patients as possible presenting with sacroiliitis or authentic axial spondylarthritis and giant cell arteritis. The investigators will also be interested in the association of spondylarthritis and polymyalgia rheumatica given the continuum between these two pathologies. The aim is to investigate whether there is an association between giant cell arteritis and spondylarthritis or polymyalgia rheumatica and spondylarthritis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Experimental group: Adult patient with spondylitis associated with GCA or PMR Control group: Adult patient with GCA or PMR
Disqualifiers
Refusal to participate
Positive anti CCP
Trial population
\- Experimental group: Adult patient with spondylitis associated with GCA or PMR Control group: Adult patient with GCA or PMR
Trial design
Design model
Case-control
Time perspective
Retrospective
Treatments tested in this trial
Description of population
Other interventionDescription of population in the aim of identify demographic or phenotypic factors different between experimental and control populations.
Treatment groups
10 Participants
are divided into 1 treatment groupGroup A: Patients with GCA, spondylarthritis and/or polymyalgia rheumatica1 intervention
Trial outcomes
Primary outcomes
1
Description of the population of patients with spondylarthritis associated with giant cell arteritis (GCA) or polymyalgia rheumatica (PMR) versus patients with GCA or PMR alone
Identification of demographic or phenotypic factors different between experimental and control populations.
Time frame
At baselineSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: